- Home
- CNTX vs CLIR Comparison
CNTX vs CLIR Comparison
Compare CNTX & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- CLIR
- Stock Information
- Founded
- CNTX 2015
- CLIR 2008
- Country
- CNTX United States
- CLIR United States
- Employees
- CNTX N/A
- CLIR N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- CNTX Health Care
- CLIR Industrials
- Exchange
- CNTX Nasdaq
- CLIR Nasdaq
- Market Cap
- CNTX 67.7M
- CLIR 59.3M
- IPO Year
- CNTX 2021
- CLIR 2012
- Fundamental
- Price
- CNTX $0.81
- CLIR $0.80
- Analyst Decision
- CNTX Strong Buy
- CLIR Strong Buy
- Analyst Count
- CNTX 5
- CLIR 1
- Target Price
- CNTX $6.70
- CLIR $6.00
- AVG Volume (30 Days)
- CNTX 147.9K
- CLIR 91.9K
- Earning Date
- CNTX 03-20-2025
- CLIR 03-31-2025
- Dividend Yield
- CNTX N/A
- CLIR N/A
- EPS Growth
- CNTX N/A
- CLIR N/A
- EPS
- CNTX N/A
- CLIR N/A
- Revenue
- CNTX N/A
- CLIR $4,280,000.00
- Revenue This Year
- CNTX N/A
- CLIR $69.16
- Revenue Next Year
- CNTX N/A
- CLIR $440.76
- P/E Ratio
- CNTX N/A
- CLIR N/A
- Revenue Growth
- CNTX N/A
- CLIR 263.02
- 52 Week Low
- CNTX $0.77
- CLIR $0.62
- 52 Week High
- CNTX $2.75
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- CNTX 39.82
- CLIR 27.40
- Support Level
- CNTX $0.77
- CLIR $0.81
- Resistance Level
- CNTX $0.87
- CLIR $1.06
- Average True Range (ATR)
- CNTX 0.08
- CLIR 0.09
- MACD
- CNTX 0.01
- CLIR -0.03
- Stochastic Oscillator
- CNTX 20.75
- CLIR 2.38
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.